Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (381-390 of 752) with videos related to

Pageof 76
Sort By:
Journal of Clinical Lipidology|April 1, 2021
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery diseaseKonstantin A Krychtiuk, Max Lenz, Philipp Hohensinner, et al.
Journal of Hypertension|November 12, 2015
Predictors of response to renal denervation for resistant arterial hypertension: a single center experienceMiklos Rohla, Alexander Nahler, Thomas Lambert, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 3, 2023
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
European Heart Journal|January 24, 2021
ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMBAllan S Jaffe, Bertil Lindahl, Evangelos Giannitsis, et al.
European Journal of Clinical Investigation|May 21, 2015
Impaired antioxidant HDL function is associated with premature myocardial infarctionKlaus Distelmaier, Franz Wiesbauer, Hermann Blessberger, et al.
The American Journal of Cardiology|September 3, 2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Sarah A Goldstein, Jennifer Green, Kurt Huber, et al.
International Journal of Cardiology|December 11, 2012
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failureBernhard Richter, Lorenz Koller, Philipp J Hohensinner, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2017
NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosisWolf Eilenberg, Stefan Stojkovic, Alexandra Kaider, et al.
European Heart Journal. Acute Cardiovascular Care|November 5, 2023
Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trialMonika Kozieł, Naab Al-Saady, Søren P Hjortshøj, et al.
Pageof 76

Showing results (381-390 of 752) with videos related to

Sort By:
Pageof 76
Journal of Clinical Lipidology|April 1, 2021
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery diseaseKonstantin A Krychtiuk, Max Lenz, Philipp Hohensinner, et al.
Journal of Hypertension|November 12, 2015
Predictors of response to renal denervation for resistant arterial hypertension: a single center experienceMiklos Rohla, Alexander Nahler, Thomas Lambert, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 3, 2023
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
European Heart Journal|January 24, 2021
ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMBAllan S Jaffe, Bertil Lindahl, Evangelos Giannitsis, et al.
European Journal of Clinical Investigation|May 21, 2015
Impaired antioxidant HDL function is associated with premature myocardial infarctionKlaus Distelmaier, Franz Wiesbauer, Hermann Blessberger, et al.
The American Journal of Cardiology|September 3, 2019
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)Sarah A Goldstein, Jennifer Green, Kurt Huber, et al.
International Journal of Cardiology|December 11, 2012
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failureBernhard Richter, Lorenz Koller, Philipp J Hohensinner, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2017
NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosisWolf Eilenberg, Stefan Stojkovic, Alexandra Kaider, et al.
European Heart Journal. Acute Cardiovascular Care|November 5, 2023
Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 10, 2020
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trialMonika Kozieł, Naab Al-Saady, Søren P Hjortshøj, et al.
Pageof 76